GATA3 and breast cancer: Clustering of patients bearing TAD mutations with BLBC patients may result from reduced activity on target genes [81] mimicking the phenotype of GATA3-low breast cancer, while an altogether divergent and discrete signature characterizes patients with DBD mutations.